Luke Utley

954 total citations
10 papers, 235 citations indexed

About

Luke Utley is a scholar working on Molecular Medicine, Hematology and Pharmacology. According to data from OpenAlex, Luke Utley has authored 10 papers receiving a total of 235 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Medicine, 4 papers in Hematology and 3 papers in Pharmacology. Recurrent topics in Luke Utley's work include Antibiotic Resistance in Bacteria (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Acute Myeloid Leukemia Research (2 papers). Luke Utley is often cited by papers focused on Antibiotic Resistance in Bacteria (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Acute Myeloid Leukemia Research (2 papers). Luke Utley collaborates with scholars based in United States and Australia. Luke Utley's co-authors include Akash Jain, Michael J. Pucci, Thomas Parr, T. P. Zabawa, Paul B. Eckburg, Susannah M. Walpole, Daniel D. Sedmak, Clark L. Anderson, Michael D. Lairmore and Charles J. Morgan and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Luke Utley

10 papers receiving 226 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luke Utley United States	7	111	86	56	55	38	10	235
Jennifer I. Smart United States	11	76 0.7×	112 1.3×	185 3.3×	102 1.9×	18 0.5×	28	366
Amudhan Murugesan India	8	96 0.9×	16 0.2×	57 1.0×	59 1.1×	89 2.3×	23	259
Bryan T. Mogle United States	5	28 0.3×	75 0.9×	129 2.3×	47 0.9×	14 0.4×	9	219
Verònica Alba Spain	12	75 0.7×	40 0.5×	70 1.3×	61 1.1×	44 1.2×	21	309
Charles Jakielaszek United States	8	94 0.8×	58 0.7×	56 1.0×	86 1.6×	9 0.2×	12	326
Renu Singh United States	11	194 1.7×	163 1.9×	46 0.8×	66 1.2×	13 0.3×	24	362
Rosy Priya Kodiyanplakkal United States	7	113 1.0×	27 0.3×	113 2.0×	66 1.2×	23 0.6×	15	285
Riccardo Ungaro Italy	9	19 0.2×	34 0.4×	169 3.0×	126 2.3×	18 0.5×	19	255
Grazia Angela Morandotti Italy	9	47 0.4×	25 0.3×	108 1.9×	102 1.9×	12 0.3×	18	289
Fatemeh Sameni Iran	9	76 0.7×	17 0.2×	63 1.1×	52 0.9×	9 0.2×	36	271

Countries citing papers authored by Luke Utley

Since Specialization

Citations

This map shows the geographic impact of Luke Utley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke Utley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke Utley more than expected).

Fields of papers citing papers by Luke Utley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luke Utley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke Utley. The network helps show where Luke Utley may publish in the future.

Co-authorship network of co-authors of Luke Utley

This figure shows the co-authorship network connecting the top 25 collaborators of Luke Utley. A scholar is included among the top collaborators of Luke Utley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luke Utley. Luke Utley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Chen, Yue, N. Nagaraja, Bin Fan, et al.. (2021). Preclinical Drug Metabolism, Pharmacokinetic, and Pharmacodynamic Profiles of Ivosidenib, an Inhibitor of Mutant Isocitrate Dehydrogenase 1 for Treatment of Isocitrate Dehydrogenase 1-Mutant Malignancies. Drug Metabolism and Disposition. 49(10). 870–881. 7 indexed citations

Falchook, Gerald S., Manish R. Patel, Timothy A. Yap, et al.. (2021). A first-in-human phase 1 study of a novel PARP7 inhibitor RBN-2397 in patients with advanced solid tumors.. Journal of Clinical Oncology. 39(15_suppl). 3000–3000. 9 indexed citations

Vasbinder, Melissa M., Laurie B. Schenkel, Kaiko Kunii, et al.. (2021). Abstract 1344: Small molecule inhibitor of CD38 modulates its intra- and extracellular functions leading to antitumor activity. Cancer Research. 81(13_Supplement). 1344–1344. 2 indexed citations

Eckburg, Paul B., Troy Lister, Susannah M. Walpole, et al.. (2019). Safety, Tolerability, Pharmacokinetics, and Drug Interaction Potential of SPR741, an Intravenous Potentiator, after Single and Multiple Ascending Doses and When Combined with β-Lactam Antibiotics in Healthy Subjects. Antimicrobial Agents and Chemotherapy. 63(9). 41 indexed citations

Eckburg, Paul B., Akash Jain, Susannah M. Walpole, et al.. (2019). Safety, Pharmacokinetics, and Food Effect of Tebipenem Pivoxil Hydrobromide after Single and Multiple Ascending Oral Doses in Healthy Adult Subjects. Antimicrobial Agents and Chemotherapy. 63(9). 32 indexed citations

Abdelraouf, Kamilia, et al.. (2018). Assessment of the In Vivo Activity of SPR741 in Combination with Azithromycin against Multidrug-Resistant Enterobacteriaceae Isolates in the Neutropenic Murine Thigh Infection Model. Antimicrobial Agents and Chemotherapy. 62(7). 22 indexed citations

Jain, Akash, Luke Utley, Thomas Parr, T. P. Zabawa, & Michael J. Pucci. (2018). Tebipenem, the first oral carbapenem antibiotic. Expert Review of Anti-infective Therapy. 16(7). 513–522. 60 indexed citations

Yang, Hua, Yue Chen, Marvin B. Cohen, et al.. (2014). Phase I Single (SAD) and Multiple Ascending Dose (MAD) Studies of the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of AG-348, a First-in-Class Allosteric Activator of Pyruvate Kinase-R, in Healthy Subjects. Blood. 124(21). 4007–4007. 2 indexed citations

Fan, Bin, Yue Chen, Fang Wang, et al.. (2014). Evaluation of Pharmacokinetic-Pharmacodynamic (PKPD) Relationship of an Oral, Selective, First-in-Class, Potent IDH2 Inhibitor, AG-221, from a Phase 1 Trial in Patients with Advanced IDH2 Mutant Positive Hematologic Malignancies. Blood. 124(21). 3737–3737. 6 indexed citations

10.

Lairmore, Michael D., Luke Utley, Charles J. Morgan, et al.. (1993). Cellular localization of CD4 in the human placenta. Implications for maternal-to-fetal transmission of HIV.. The Journal of Immunology. 151(3). 1673–1681. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact